ALFA Filings
Every announcement, straight from the exchange
Every Sun Pharmaceutical Industries credit rating announcement on NSE and BSE, newest first, each with its own page.
Time
4 announcements
Sun Pharma received credit ratings from CRISIL and ICRA for its proposed NCD programme and reaffirmed existing facility ratings.
Sun Pharma has been assigned international issuer credit ratings of Baa1 by Moody’s and BBB+ by S&P. These investment-grade ratings reflect the company's strong financial profile.
CRISIL reaffirmed Sun Pharmaceutical Industries' long-term bank facilities rating at 'CRISIL AAA/Stable'. The 'Rating Watch with Developing Implications' status has been officially removed.
Sun Pharmaceutical Industries Limited announced that CRISIL and ICRA reaffirmed its 'AAA' and 'A1+' ratings. CRISIL placed the long-term rating on 'Watch with Developing Implications' following Sun Pharma's agreement to acquire Organon & Co.